Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Seshu Tyagarajan

CTO at Candel Therapeutics, Inc. (CADL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $154K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 19SEC CADLCandel Therapeutics, Inc. Sell Plan 7,00076,865 held (−8%) $12.00 $84K -31.8%
Jul 1SEC CADLCandel Therapeutics, Inc. Sell Plan 7,00083,865 held (−8%) $10.02 $70K -18.3%
  • Sell

    CTO Seshu Tyagarajan sold $84K of CADL at $12.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CTO Seshu Tyagarajan sold $70K of CADL at $10.02 — pre-scheduled 10b5-1 plan sale.